Biology subjects

Drummond, R.

Publications and source records attributed to Drummond, R..

6 recordsLinked to original sources

bioRxiv2026

Chromatin priming and co-factor availability shape lineage response to the neuronal pioneer factor ASCL1 in pluripotency

Transcription factors act within defined developmental windows, yet how naive pluripotent cells acquire competence to execute specific transcription factor-driven fate programmes remains unclear. Pioneer transcription factors that engage target sites in closed chromatin to initiate gene expression programmes often act at the top of hierarchies in cell identity transitions. However, we show that the ability of ASCL1 to induce a coherent neuronal programme emerges only after exit from pluripotency, coincident with progressive chromatin remodelling and accumulation of permissive histone marks at neuronal ASCL1 target sites. Binding analysis reveals that although ASCL1 can access a subset of neuronal loci in mESCs and EpiLCs, ASCL1 is preferentially diverted to non-neuronal sites, resulting in divergent transcriptional responses. Increasing global histone acetylation enhances activation of individual neuronal genes but is insufficient to drive full neuronal differentiation. In contrast, co-expression of the homeodomain transcription factor PHOX2B redirects ASCL1 towards neuronal targets while suppressing inappropriate programmes in mESCs. These findings demonstrate that ASCL1 pioneer activity is highly context-dependent and that developmental priming of chromatin is essential for appropriate lineage specification. HIGHLIGHTSO_LIEctopic ASCL1 drives non-neuronal transcriptional responses in naive and formative pluripotent cells C_LIO_LIASCL1 occupies distinct, predominantly non-neuronal genomic targets in pluripotent cells due to differential chromatin accessibility C_LIO_LIASCL1 pioneer activity is locus- and cell type-specific and predicted by histone acetylation status C_LIO_LICo-expression of ASCL1 with Phox2 homeodomain cofactors potentiates neuronal lineage acquisition in pluripotent cells C_LI

developmental biology↗

bioRxiv2026

Hierarchical TBX6-FOXC Regulatory Logic Controls Human Trunk Mesoderm Diversification

Mesoderm forms during gastrulation and diversifies to generate many embryonic tissues, yet the regulatory logic governing early human mesodermal lineage decisions remains poorly defined. We use human iPSC-derived 3D trunk-like structures (hTLS) to model lineage specification during early post-gastrulation development, a stage experimentally inaccessible in humans. Developing hTLS generate neural and mesodermal lineages and recapitulate progressive mesodermal diversification into paraxial (somitic) and intermediate (renal) identities. Using genetic perturbations and temporally controlled transcription factor activation, we identify duration-dependent TBX6 activity as a critical determinant of mesodermal diversification. Downstream, the forkhead box transcription factors FOXC1 and FOXC2 stabilise somitic identity and are required for sclerotome differentiation. These findings reveal a duration-dependent hierarchical regulatory logic in early human mesoderm, in which competence for diversification is established before downstream lineage identities are stabilised, positioning hTLS as a powerful platform to experimentally dissect human developmental programs. HighlightsO_LIHuman trunk-like structures model mesodermal diversification during early post-gastrulation human trunk development C_LIO_LITBX6 duration acts as a temporal gate controlling mesodermal fate potential C_LIO_LIFOXC1/2 function downstream of TBX6 to lock in somitic identity and restrict alternative fates C_LIO_LIDegTrace enables lineage tracing following transient transcription factor activation C_LI

developmental biology↗

bioRxiv2025

Comparative ASCL1 interactome analysis reveals CDK2-Cyclin A2 as suppressors of differentiation in MYCN-amplified neuroblastoma

Neuroblastoma is a heterogeneous paediatric cancer arising from developmentally arrested neuronal precursors, where restoring differentiation offers therapeutic promise. ASCL1, a pro-neural transcription factor, is widely expressed in neuroblastoma and can drive either proliferation or differentiation depending on the cellular context. Here, we show that distinct MYCN-amplified neuroblastoma cell lines exhibit differing cell cycle and differentiation responses to ASCL1 overexpression. By comparing genome-wide ASCL1 chromatin binding, transcriptional changes, and protein-protein interactions, we found that ASCL1 binds more extensively to neuronal proteins in a cell line that is more susceptible to ASCL1-driven differentiation, but associates with cell cycle regulators in less responsive cells. We show that CDK2-Cyclin A2 bind ASCL1 in less responsive cells, with CDK-mediated phosphorylation of ASCL1 limiting the ability of ASCL1 to drive differentiation. Our study reveals that context-dependent interactions of ASCL1 with protein partners on the chromatin control its ability to re-engage a differentiation program in neuroblastoma.

cancer biology↗

bioRxiv2020

Characteristics of Titan cell formation vary across clinical isolates of Cryptococcus neoformans

Fungal morphology significantly impacts the host response. Filamentation and tissue penetration by Candida and Aspergillus species are essential for virulence, while growth as a yeast allows the thermal dimorphic fungi Coccidiodes, Histoplasma, and Talaromyces to reside inside phagocytes and disseminate. The basidiomycete Cryptococcus neoformans exhibits an unusual yeast-to-titan transition thought to enhance pathogenicity by increasing fungal survival in the host lung and dissemination to the central nervous system. In a common laboratory strain (H99), in vitro and in vivo titan induction yields a heterogenous population including >10 m titan cells, 5-7 m yeast cells and 2-4 m titanides. Previous reports have shown that titan cells are associated with enhanced virulence and the generation of aneuploid cells that facilitate stress adaptation and drug resistance, while small (>10 m) cells are associated with increased dissemination. However, the relationship between titan cells, small cells, and titanides remains unclear. Here, we characterize titanides and small cells in H99 and three clinical isolates and show that titanides share the lipid membrane order of their titan mothers and the G0 quiescent-like DNA staining of mating spores. In addition, we show that both titanizing and non-titanizing isolates exhibit altered capsule structure and PAMP exposure over time during in vitro culture, and generate aneuploidy in vivo. Author summaryThe human fungal pathogen Cryptococcus neoformans causes 200,000 HIV-associated deaths each year. In the lung, Cryptococcus makes an unusual yeast-to-titan morphological switch that contributes to disease development by altering immune polarization and introducing aneuploidy underlying host stress and drug resistance. Specifically, a proportion of 5 um haploid yeast endoreduplicate and swell, converting to large (> 10 um) polyploid titan cells that can then produce genetically distinct daughter cells. We recently developed an in vitro protocol for inducing large titan cells and additionally observed a novel small "titanide" cell type. Here we investigate the nature and origin of these small cells, demonstrating that they emerge during both in vitro and in vivo mouse-passaged titan induction in the well characterised lab strain H99 and are also apparent in a titanizing clinical isolate, Zc8. We show that these titanide cells share features with titan mothers (lipid order) and with spores produced during heterothalic mating. Finally, we show that the capacity of clinical isolates to produce both titan and titanide cells impacts aneuploidy and the emergence of drug resistance in vivo.

microbiology↗

bioRxiv2019

Efficient RNA-mediated reprogramming of human somatic cells to naive pluripotency facilitated by tankyrase inhibition

In contrast to conventional human pluripotent stem cells (hPSC) that are related to post-implantation embryo stages, naive hPSC exhibit features of pre-implantation epiblast. Naive hPSC are established by resetting conventional hPSC, or are derived from dissociated embryo inner cell masses. Here we investigate conditions for transgene-free reprogramming of human somatic cells to naive pluripotency. We find that tankyrase inhibition promotes RNA-mediated induction of naive pluripotency. We demonstrate application to independent human fibroblast cultures and endothelial progenitor cells. We show that induced naive hPSC can be clonally expanded with a diploid karyotype and undergo somatic lineage differentiation following formative transition. Induced naive hPSC lines exhibit distinctive surface marker, transcriptome, and methylome properties of naive epiblast identity. This system for efficient, facile, and reliable induction of transgene free naive hPSC offers a robust platform, both for delineation of human reprogramming trajectories and for evaluating the attributes of isogenic naive versus conventional hPSC.

developmental biology↗

bioRxiv2018

APOBEC-mediated DNA alterations: a possible new mechanism of carcinogenesis in EBV-positive gastric cancer

Mechanisms of viral oncogenesis are diverse and include the off-target activity of enzymes expressed by the infected cells, which evolved to target viral genomes for controlling their infection. Among these enzymes, the single-strand DNA editing capability of APOBECs represent a well-conserved viral infection response that can also cause untoward mutations in host DNA. Here we show, after evaluating somatic single-nucleotide variations and transcriptome data in 240 gastric cancer samples, a positive correlation between APOBEC3s mRNA-expression and the APOBEC-mutation signature, both increased in EBV+ tumors. The correlation was reinforced by the observation of APOBEC-mutations preferentially occuring in transcriptionally-active loci. The EBV-infection and APOBEC3 mutation-signature axis was confirmed in a validation cohort of 112 gastric cancer patients. Our findings suggest that APOBEC3 upregulation in EBV+ cancer may boost the mutation load, providing further clues to the mechanisms of EBV-induced gastric carcinogenesis. After further validation, this EBV-APOBEC axis may prove to be a secondary driving force in the mutational evolution of EBV+ gastric tumors, whose consequences in terms of prognosis and treatment implications should be vetted.

cancer biology↗